COMPANY OVERVIEW

Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark’s pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson’s disease.

---

LOCATION

Rye, NY, USA

---

THERAPEUTIC AREAS

Neurological DIsorders

---

WEBSITE

https://www.linkedin.com/company/761581/

---

CAREER WEBSITE

https://curemark.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Sep 22, 2022

Curemark Announces the Key Addition of Dr. William R. McIntyre as Senior Vice President of Global Regulatory Affairs

Feb 14, 2022

Curemark Announces the Promotion of Chiwon Yang to Vice President of Manufacturing Sciences and Technology

Sep 29, 2021

Curemark Announces The Appointment of Afia Asamoah To The Board of Directors

Oct 28, 2020

Curemark Announces The Appointment Of Leigh Morgan To The Board Of Directors

Oct 14, 2020

CUREMARK Honored by Goldman Sachs for Entrepreneurship

For More Press Releases

---